The de-linkage of R&D costs and drug prices through the Prize Fund for HIV/AIDS will cost less, expand access, accelerate and improve innovation, and replace an incentive system that is expensive, inefficient and unsustainable. James Love’s testimony before Senate Subcommittee on Primary Health and Aging.
|By: James Love Tuesday May 15, 2012 7:01 am|
|By: Wendell Potter Sunday November 27, 2011 1:59 pm|
Just last week, the 34-nation Organization for Economic Cooperation Development (OECD) released the results of its most recent study of the health care systems in the 40 counties considered to be “developed.” It came as no surprise to see that the U.S. health care system—if we can even call it a system—is still by far the most expensive on the planet.
We spend two-and-a-half times more on health care per person than the OECD average.
After reading Dr. John Geyman’s latest book, Breaking Point—How the Primary Care Crisis Endangers the Lives of Americans, I now understand why and how we have sunk so low.